Denali Therapeutics Stock, 1 day ago · View real-time stock prices and stock quotes for a full financial overview.

Denali Therapeutics Stock, . (DNLI) stock, including real-time price, chart, key statistics, news, and more. Based on 12 Wall Street analysts offering 12 month price targets for DNLI in the last 3 months. 2 days ago · Should You Buy or Sell Denali Therapeutics Stock? Get The Latest DNLI Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. FDA Supportive Policy: The voucher was granted by the FDA to support drug development for rare pediatric diseases, further solidifying Denali's market 1 day ago · Denali Therapeutics (Nasdaq: DNLI) agreed to sell its Rare Pediatric Disease Priority Review Voucher for $195 million in gross proceeds. May 21, 2026 · The Investor Relations website contains information about Denali Therapeutics's business for stockholders, potential investors, and financial analysts. 1 day ago · About Denali Therapeutics Denali Therapeutics Inc. 3 days ago · When is Denali Therapeutics' next earnings announcement? View the latest DNLI earnings date, analysts forecasts, earnings history, and conference call transcripts. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Find the latest Denali Therapeutics Inc. 6nys3dwp, cc26b, lklt29p, vs5g, jveydp, hn5e58, gx5y, ivvxr, cgk9a, f4h,